NeuroPace NPCE Stock
NeuroPace Price Chart
NeuroPace NPCE Financial and Trading Overview
| NeuroPace stock price | 15.88 USD |
| Previous Close | 16.54 USD |
| Open | 16.5 USD |
| Bid | 11.71 USD x 200 |
| Ask | 20.17 USD x 200 |
| Day's Range | 15.64 - 16.64 USD |
| 52 Week Range | 7.56 - 19.6 USD |
| Volume | 166.62K USD |
| Avg. Volume | 210.53K USD |
| Market Cap | 562.89M USD |
| Beta (5Y Monthly) | 1.929 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.65 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 USD |
NPCE Valuation Measures
| Enterprise Value | 580.39M USD |
| Trailing P/E | N/A |
| Forward P/E | -55.542473 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.655458 |
| Price/Book (mrq) | 29.118168 |
| Enterprise Value/Revenue | 5.831 |
| Enterprise Value/EBITDA | -35.154 |
Trading Information
NeuroPace Stock Price History
| Beta (5Y Monthly) | 1.929 |
| 52-Week Change | 26.84% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 19.6 USD |
| 52 Week Low | 7.56 USD |
| 50-Day Moving Average | 15.67 USD |
| 200-Day Moving Average | 13.79 USD |
NPCE Share Statistics
| Avg. Volume (3 month) | 210.53K USD |
| Avg. Daily Volume (10-Days) | 147.95K USD |
| Shares Outstanding | 34.09M |
| Float | 23.31M |
| Short Ratio | 2.87 |
| % Held by Insiders | 3.98% |
| % Held by Institutions | 96.26% |
| Shares Short | 613.82K |
| Short % of Float | 2.06% |
| Short % of Shares Outstanding | 1.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -21.66% |
| Operating Margin (ttm) | -25.23% |
| Gross Margin | 78.29% |
| EBITDA Margin | -16.58% |
Management Effectiveness
| Return on Assets (ttm) | -10.018% |
| Return on Equity (ttm) | -111.38% |
Income Statement
| Revenue (ttm) | 99.53M USD |
| Revenue Per Share (ttm) | 2.99 USD |
| Quarterly Revenue Growth (yoy) | -2.00000000000000000000000000000000% |
| Gross Profit (ttm) | 77.93M USD |
| EBITDA | -16510000 USD |
| Net Income Avi to Common (ttm) | -21565000 USD |
| Diluted EPS (ttm) | -0.65 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 53.98M USD |
| Total Cash Per Share (mrq) | 1.58 USD |
| Total Debt (mrq) | 70.46M USD |
| Total Debt/Equity (mrq) | 487.49 USD |
| Current Ratio (mrq) | 5.38 |
| Book Value Per Share (mrq) | 0.567 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9424000 USD |
| Levered Free Cash Flow (ttm) | -2739000 USD |
Profile of NeuroPace
| Country | United States |
| State | CA |
| City | Mountain View |
| Address | 455 North Bernardo Avenue |
| ZIP | 94043 |
| Phone | 650 237 2700 |
| Website | https://www.neuropace.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 220 |
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Q&A For NeuroPace Stock
What is a current NPCE stock price?
NeuroPace NPCE stock price today per share is 15.88 USD.
How to purchase NeuroPace stock?
You can buy NPCE shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NeuroPace?
The stock symbol or ticker of NeuroPace is NPCE.
Which industry does the NeuroPace company belong to?
The NeuroPace industry is Medical Devices.
How many shares does NeuroPace have in circulation?
The max supply of NeuroPace shares is 34.09M.
What is NeuroPace Price to Earnings Ratio (PE Ratio)?
NeuroPace PE Ratio is now.
What was NeuroPace earnings per share over the trailing 12 months (TTM)?
NeuroPace EPS is -0.65 USD over the trailing 12 months.
Which sector does the NeuroPace company belong to?
The NeuroPace sector is Healthcare.
NeuroPace NPCE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
- {{ link.label }} {{link}}